CD209 and neoplasm: Post-treatment, the tumor microenvironment showed immunomodulatory changes, including altered macrophage infiltration and significant gene expression changes related to inflammation and immune response, such as IDO1, IL-6, TNF, CD209, and FOXP3 [40].